Tekla Life Sciences Investors (HQL)

US — Financial Services Sector
Peers: THW  THQ  RVT  BTO  HQH  DFP  UTF  ETG  MYD  EVT  ETB  NXC  RNP  XFLT  JPI  FPF  FFC  ETJ 

Automate Your Wheel Strategy on HQL

With Tiblio's Option Bot, you can configure your own wheel strategy including HQL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HQL
  • Rev/Share 0.1383
  • Book/Share 15.977
  • PB 0.7811
  • Debt/Equity 0.0
  • CurrentRatio 0.3169
  • ROIC -0.0041

 

  • MktCap 360327552.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE 4.2098
  • Debt/Assets 0.0
  • DivYield 0.1514
  • ROE 0.1894

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 4
  • DCF Score 1
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
BCAT, BSTZ, HQL
Published: April 30, 2025 by: The Motley Fool
Sentiment: Positive

My definition of a high yield is any yield at least twice the level of the S&P 500's yield. The threshold is currently around 2.56%.

Read More
image for news These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X
HQL
Published: February 11, 2025 by: Seeking Alpha
Sentiment: Positive

HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X

Read More
image for news HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X

About Tekla Life Sciences Investors (HQL)

  • IPO Date 1992-05-01
  • Website https://www.teklacap.com/hql.html
  • Industry Asset Management
  • CEO Dr. Daniel R. Omstead M.S, Ph.D.
  • Employees None
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.